NCT02513862View on ClinicalTrials.gov

Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

October 31, 2016

Conditions
C.Surgical Procedure; Cardiac
Interventions
DEVICE

Autologous Platelet-Rich Plasma Harvest Technique

15 to 20 mL/kg of whole blood is collected before the administration of heparin from a large-bore central venous access,and is separated into red blood cells component and autologous platelet-rich plasma component by an autologous transfusion system(Sorin Group Electa Essential; Sorin Group Italia, Milan, Italy).

Trial Locations (1)

100037

Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC, Beijing

All Listed Sponsors
lead

Hongwen Ji

OTHER

NCT02513862 - Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery | Biotech Hunter | Biotech Hunter